0001104659-21-065889.txt : 20210615 0001104659-21-065889.hdr.sgml : 20210615 20210513153532 ACCESSION NUMBER: 0001104659-21-065889 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 CORRESP 1 filename1.htm

Sesen Bio, Inc.

245 First Street, Suite 1800

Cambridge, MA 02142

May 13, 2021

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attn: Deanna Virginio

Re:	Sesen Bio, Inc.
	Registration Statement on Form S-3
	Filed May 10, 2021
	File No. 333-255943

Request for Acceleration of Effective Date

Dear Ms. Virginio:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Sesen Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Daylight Time, on May 14, 2021, or as soon thereafter as possible.

Please feel free to direct any questions or comments concerning this request to Steve Abrams of Hogan Lovells US LLP at (267) 675-4671.

	Very truly yours,

	Sesen Bio, Inc.

	/s/ Thomas R. Cannell, D.V.M.
	By:	Thomas R. Cannell, D.V.M.
	Title:	President and Chief Executive Officer